CELL SIGNALING TECHNOLOGY, INC.

MOTIF-SPECIFIC AND CONTEXT-INDEPENDENT ANTIBODIES THAT SPECIFICALLY BIND TO A SUMOYLATED LYSINE-CONTAINING RESIDUE

#2 | 2022-08-25

US20220267854A1

EGFR AND ROS1 KINASE IN CANCER

#3 | 2022-01-06

US20220003771A1

METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER

#4 | 2021-12-02 ✅ Patent 11,505,833 granted on 2022-11-22

US20210371933A1

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#5 | 2021-11-11

US20210349095A1

ROS KINASE IN LUNG CANCER

#6 | 2021-04-29 ✅ Patent 11,428,696 granted on 2022-08-30

US20210123924A1

Mass spectrometry analysis of mutant polypeptides in biological samples

#7 | 2021-03-18

US20210079445A1

Multi Component Detection

#8 | 2021-03-04 ✅ Patent 11,761,005 granted on 2023-09-19

US20210062196A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#9 | 2020-11-19

US20200363417A1

METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER

#10 | 2020-10-08 ✅ Patent 11,377,486 granted on 2022-07-05

US20200317760A1

Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue

#11 | 2020-04-30 ✅ Patent 11,352,418 granted on 2022-06-07

US20200131254A1

Analysis of ubiquitinated polypeptides

#12 | 2020-03-12

US20200080159A1

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#13 | 2019-05-02 ✅ Patent 11,099,188 granted on 2021-08-24

US20190128889A1

ROS kinase in lung cancer

#14 | 2019-05-02 ✅ Patent 10,870,892 granted on 2020-12-22

US20190127804A1

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#15 | 2019-02-14 ✅ Patent 10,955,416 granted on 2021-03-23

US20190049449A1

Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer

#16 | 2019-01-24 ✅ Patent 10,670,606 granted on 2020-06-02

US20190025322A1

Mass spectrometry analysis of mutant polypeptides in biological samples

#17 | 2019-01-03

US20190002532A1

METHODS AND REAGENTS FOR CREATING MONOCLONAL ANTIBODIES

#18 | 2018-06-07

US20180156802A1

METHODS OF TREATING LUNG CANCER BY ADMINISTRATION OF AN ALK INHIBITOR

#19 | 2017-09-28

US20170275706A1

ALK AND ROS KINASE IN CANCER

#20 | 2017-07-27 ✅ Patent 10,577,640 granted on 2020-03-03

US20170211124A1

Multi component detection

#21 | 2017-07-20 ✅ Patent 10,036,756 granted on 2018-07-31

US20170205422A1

Mass spectrometry analysis of mutant polypeptides in biological samples

#22 | 2017-03-16

US20170071941A1

MUTANT ROS EXPRESSION IN HUMAN CANCER

#23 | 2016-11-17 ✅ Patent 9,523,130 granted on 2016-12-20

US20160333425A1

Methods of treating non-small cell lung carcinoma (NSCLC)

#24 | 2016-07-28 ✅ Patent 10,526,661 granted on 2020-01-07

US20160215353A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#25 | 2016-06-30 ✅ Patent 9,988,688 granted on 2018-06-05

US20160186268A1

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#26 | 2016-05-19 ✅ Patent 9,856,315 granted on 2018-01-02

US20160137725A1

Methylation and acetylation sites

#27 | 2015-12-24 ✅ Patent 10,551,383 granted on 2020-02-04

US20150369810A1

Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer

#28 | 2015-09-17 ✅ Patent 9,738,711 granted on 2017-08-22

US20150259405A1

Production of motif-specific and context-independent antibodies using peptide libraries as antigens

#29 | 2015-07-02

US20150185220A1

CANCER CLASSIFICATION AND METHODS OF USE

#30 | 2015-07-02

US20150184158A1

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#31 | 2015-04-30 ✅ Patent 9,539,254 granted on 2017-01-10

US20150119403A1

Mutant ROS expression in human cancer

#32 | 2015-02-26

US20150056193A1

EGFR AND ROS1 KINASE IN CANCER

#33 | 2015-01-29 ✅ Patent 9,588,110 granted on 2017-03-07

US20150031563A1

Multi component antibody based detection technology

#34 | 2015-01-08 ✅ Patent 9,328,349 granted on 2016-05-03

US20150010577A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#35 | 2014-05-15

US20140134640A1

Gene Defects And Mutant ALK Kinase In Human Solid Tumors

#36 | 2014-04-03 ✅ Patent 9,587,013 granted on 2017-03-07

US20140094594A1

Immunoaffinity isolation of modified peptides from complex mixtures

#37 | 2013-10-31

US20130288240A1

ALK AND ROS KINASE IN CANCER

#38 | 2013-10-10

US20130266965A1

Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHA

#39 | 2013-09-19 ✅ Patent 9,102,713 granted on 2015-08-11

US20130245237A1

Analysis of ubiquitinated polypeptides

#40 | 2013-08-15

US20130209452A1

GENE DEFECTS AND MUTANT ALK KINASE IN HUMAN SOLID TUMORS

#41 | 2013-03-21

US20130071841A1

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#42 | 2013-03-07 ✅ Patent 10,889,818 granted on 2021-01-12

US20130059305A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#43 | 2013-03-07

US20130059304A1

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#44 | 2013-01-03 ✅ Patent 8,618,260 granted on 2013-12-31

US20130004963A1

Tyrosine, serine and threonine phosphorylation sites

#45 | 2012-12-06 ✅ Patent 9,920,110 granted on 2018-03-20

US20120308555A1

Methods and reagents for creating monoclonal antibodies

#46 | 2012-11-15 ✅ Patent 8,486,645 granted on 2013-07-16

US20120288872A1

Gene defects and mutant ALK kinase in human solid tumors

#47 | 2012-08-16 ✅ Patent 9,249,231 granted on 2016-02-02

US20120208985A1

Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motif

#48 | 2012-08-16

US20120208824A1

ROS Kinase in Lung Cancer

#49 | 2012-07-05 ✅ Patent 8,481,279 granted on 2013-07-09

US20120171696A1

Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase

#50 | 2012-06-14

US20120149880A1

Nucleic Acid Cassette For Producing Recombinant Antibodies

#51 | 2012-04-26

US20120101108A1

Anaplastic Lymphoma Kinase In Kidney Cancer

#52 | 2012-04-19 ✅ Patent 10,000,568 granted on 2018-06-19

US20120093837A1

Compositions and methods for detecting EGFR in cancer

#53 | 2011-11-24 ✅ Patent 9,364,477 granted on 2016-06-14

US20110287445A1

Mutant ROS expression in human cancer

#54 | 2011-10-06 ✅ Patent 9,453,845 granted on 2016-09-27

US20110244445A1

Mass spectroscopy analysis of mutant polypeptides in biological samples

#55 | 2011-09-15 ✅ Patent 8,232,060 granted on 2012-07-31

US20110223609A1

Gene defects and mutant ALK kinase in human solid tumors

#56 | 2011-08-11 ✅ Patent 8,466,160 granted on 2013-06-18

US20110195447A1

Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha

#57 | 2011-06-16

US20110143368A1

Tyrosine phosphorylation sites

#58 | 2011-06-02

US20110130547A1

Reagents For The Detection Of Protein Phosphorylation In EGFR Signaling Pathways

#59 | 2011-05-12

US20110111424A1

ANALYSIS OF UBIQUITINATED POLYPEPTIDES

#60 | 2011-05-05

US20110104820A1

Tyrosine, Serine, And Threonine Phosphorylation Sites

#61 | 2011-03-10

US20110059463A1

Serine and Threonine Phosphorylation Sites

#62 | 2011-02-24

US20110045603A1

Serine, Threonine, and Tyrosine Phosphorylation Sites

#63 | 2011-02-24

US20110045534A1

Nucleic Acid Cassette For Producing Recombinant Antibodies

#64 | 2011-01-27 ✅ Patent 8,377,642 granted on 2013-02-19

US20110021546A1

Gene defects and mutant ALK kinase in human solid tumors

#65 | 2010-12-02 ✅ Patent 8,288,102 granted on 2012-10-16

US20100304382A1

Gene defects and mutant ALK kinase in human solid tumors

#66 | 2010-11-25 ✅ Patent 8,383,799 granted on 2013-02-26

US20100298404A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#67 | 2010-10-21

US20100266580A1

TRANSLOCATION AND MUTANT TNK1 KINASE IN HUMAN LYMPHOMA

#68 | 2010-09-23 ✅ Patent 8,168,383 granted on 2012-05-01

US20100240034A1

Gene defects and mutant ALK kinase in human solid tumors

#69 | 2010-09-02 ✅ Patent 9,096,855 granted on 2015-08-04

US20100221737A1

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#70 | 2010-08-26

US20100216718A1

Cancer Classification and Methods of Use

#71 | 2010-06-17

US20100151483A1

REAGENTS FOR THE DETECTION OF PROTEIN PHOSPHORYLATION IN SIGNALING PATHWAYS

#72 | 2010-06-10

US20100143918A1

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#73 | 2010-06-08 ✅ Patent 7,731,964 granted on 2010-06-08

US10694874

Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereof

#74 | 2010-05-13

US20100120055A1

TYROSINE PHOSPHORYLATION SITES

#75 | 2009-12-31

US20090325189A1

Tyrosine phosphorylation sites

#76 | 2009-11-19

US20090285796A1

MUTANT JAK3 KINASE IN HUMAN LEUKEMIA

#77 | 2009-10-15 ✅ Patent 7,999,080 granted on 2011-08-16

US20090258436A1

Reagents for the detection of protein phosphorylation in signaling pathways

#78 | 2009-06-18 ✅ Patent 7,700,339 granted on 2010-04-20

US20090156475A1

Gene defects and mutant ALK kinase in human solid tumors

#79 | 2009-04-16 ✅ Patent 7,977,462 granted on 2011-07-12

US20090098581A1

Tyrosine phosphorylation sites

#80 | 2009-03-26 ✅ Patent 7,833,736 granted on 2010-11-16

US20090081709A1

Protein markers of responsiveness to type III receptor tyrosine kinase inhibitors

#81 | 2008-10-09 ✅ Patent 7,888,480 granted on 2011-02-15

US20080248490A1

Reagents for the detection of protein phosphorylation in leukemia signaling pathways

#82 | 2008-05-08 ✅ Patent 7,807,789 granted on 2010-10-05

US20080108795A1

Reagents for the detection of protein phosphorylation in EGFR-signaling pathways

#83 | 2008-03-18 ✅ Patent 7,344,714 granted on 2008-03-18

US10139841

Production of motif-specific and context-independent antibodies using peptide libraries as antigens

#84 | 2007-08-21 ✅ Patent 7,259,022 granted on 2007-08-21

US10014485

Production of motif-specific and context-independent antibodies using peptide libraries as antigens

#85 | 2007-07-19 ✅ Patent 7,906,297 granted on 2011-03-15

US20070166764A1

Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof

#86 | 2007-06-28 ✅ Patent 7,932,044 granted on 2011-04-26

US20070148711A1

Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α

#87 | 2007-04-03 ✅ Patent 7,198,896 granted on 2007-04-03

US10175486

Immunoaffinity isolation of modified peptides from complex mixtures

#88 | 2007-03-29 ✅ Patent 7,973,134 granted on 2011-07-05

US20070072235A1

Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways

#89 | 2007-02-27 ✅ Patent 7,183,385 granted on 2007-02-27

US10368912

Phospho-specific antibodies to Flt3 and uses thereof

#90 | 2007-02-01 ✅ Patent 9,085,609 granted on 2015-07-21

US20070026461A1